ClinicalTrials.gov
public full text
Public Domain
Efficacy of Melatonin in Decreasing the Incidence of Delirium in End of Life Patients
The purpose of this study is to determine if melatonin administration to end-of-life patients is effective in preventing the development of delirium compared with those who do not receive this treatment. Delirium is a difficult to control symptom commonly seen in patients at the end-of-life. A person who is delirious is unable to think clearly and cannot make sense of what is going on around him/her.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Trial to Reduce Delirium in Aged Post Acute Patients#967378
- Efficacy of the Administration of Melatonin 5mg in the Prevention of Delirium in Older Adults Hospitalized in the Emergency Department#898736
- Agitation Severity and Psychotropic Prescription in Acute Patients With Delirium Superimposed on Dementia.#143058
- Melatonin prescribing characteristics and delirium outcomes: A health system database-based study.#285077
- Nonpharmacological interventions for preventing delirium in adult patients with cancer: a systematic review and meta-analysis.#340310
Record · ID 1432100
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive